Reprotoxic activities of vildagliptin administration in male Wistar rats
DOI:
https://doi.org/10.1590/s2175-97902020000119144Palavras-chave:
Vildagliptin. Sperm. Testosterone. Testis. Rats.Resumo
Vildagliptin is an oral hypoglycemic agent used in the management of diabetes. Some oral antidiabetic drugs have been implicated in reproductive toxicity.The objective of this study was to investigate the effects of daily administration of vildagliptin at different dosages (0.35 mg/kg B.W., 0.70 mg/kg B.W. and 1.40 mg/kg B.W.) to male Wistar rats for 8 weeks. Sperm parameters, serum concentrations of testosterone, follicle stimulating hormone and luteinizing hormone and the histology of the testis of the rats were assessed. Another set of rats were also treated for 8 weeks and allowed to recover and the same parameters were assessed in them. Fertility study was conducted by determining their litter size. The results showed that vildagliptin administration significantly reduced sperm count and motility of the treated rats. It also significantly increased the number of abnormal sperms. Serum level of testosterone was significantly decreased while luteinizing hormone and follicle stimulating hormone levels showed no significant change. The histoarchitecture of the testis of the treated rats appeared visibly normal. The litter size was also significantly reduced. Most of the changes observed were dose dependent. However, these parameters were restored towards normal in the recovery group. Our results suggest that vildagliptin adversely affected sperm parameters, affected litter size and disrupted the pituitary – gonadal axis. These changes were however reversed upon cessation of drug administration.
Downloads
Referências
Agrawal Y, Vanha-Perttula T. Dipeptidyl peptidases in bovine reproductive organs and secretions. Int J Androl. 1986;9(6):435-452. PMID: 3570534.
Ahmed MA, Kurkar A. Effects of opioid (tramadol) treatment on testicular functions in adult male rats: the role of nitric oxide and oxidative stress. Clin Exp Pharmacol Physiol. 2014;41(4):317-323. doi:10.1111/1440-1681.12213.
» https://doi.org/10.1111/1440-1681.12213
Ahren B, Foley JE. The islet enhancer vildagliptin: Mechanism of increased glucose metabolism. Int J Clin Pract Suppl. 2008;62(159):8-14. doi: 10.1111/j.1742-1241.2007.01685x.
» https://doi.org/10.1111/j.1742-1241.2007.01685x
Ahren B, Gomis R, Standl E, Mills D, Schweizer A. Twelve and 52-week efficacy of dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes. Diabetes Care. 2004;27(12):2874-2880. PMID: 15562200.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539553. doi: 10.1002/(SICI)1096-9136(199807)15:7<539:AIDDIA668>3.0.CO;2-S.
» https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539:AIDDIA668>3.0.CO;2-S
Amaral S, Oliveira PJ, Ramalho-Santos J. Diabetes and impairment of reproductive function: possible role of mitochondria and reactive oxygen species. Curr Diabetes Rev. 2008;4(1):46-54. PMID: 18220695.
Arienti G, Polci A, Carlini E, Palmerini CA. Transfer of CD 26/dipeptidyl peptidase IV (E.C. 3.5.4.4) from prostasomes to sperm. FEBS Lett. 1997; 410(2-3):343-346.
Ayuob NN, Murad HA, Ali SS. Impaired expression of sex hormone receptors in male reproductive organs of diabetic rat in response to oral antidiabetic drugs. Folia Histochem Cytobiol. 2015;53(1):35-48. doi: 10.5603/FHC.a2015.0005. Epub.
» https://doi.org/10.5603/FHC.a2015.0005
Bebb RA. Testosterone deficiency: practical guidelines for diagnosis and treatment. B C Med J. 2011;53(9):474-479.
Bergeson B. Vildagliptin side effects. Livestrong.com. 2015.
Bertoldo MJ, Faure M, Dupont J, Froment P. Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation. Ann Transl Med. 2014;2(6):108117. doi: 10.3978/j.issn.2305-5839.2014.06.04.
» https://doi.org/10.3978/j.issn.2305-5839.2014.06.04
Blasiak J, Arabski M, Krupa R, Wozniak K, Zadrozny M, Kaszniki J, Zurawska M, Drzewoski J. DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 2004;554(12):297-304.
Boron WF, Oulapaep EL. Medical Physiology. Philadelphia Elsevier Saunders. 2nd edition: 2009;1016-1017.
Crosnoe-Shipley L, Elkelany O, Rahnema C, Kim E. Treatment of hypogonadotropic male hypogonadism: casebased scenarios. World J Nephrol. 2015;4(2):245-253. doi: 10.5527/wjn.v4.i2.245.
» https://doi.org/10.5527/wjn.v4.i2.245
Croxtall JD, Keam SJ. Vildagliptin: a review of its use in the management of type 2 diabetes mellitus. Drugs. 2008;68(16):2387-2409. https://doi.org/10.2165/0003495200868160-00009
» https://doi.org/10.2165/0003495200868160-00009
Dicker D. DPP-4 inhibitors: Impact on glycemic control and cardiovascular risk factors. Diabetes Care. 2011;34(2):S276-S278. https://doi.org/10.2337/dc11-s229
» https://doi.org/10.2337/dc11-s229
Ekhoye EI, Nwangwa EK, Aloamaka CP. Changes in some testicular biometric parameters and testicular function in cadmium chloride administered Wistar rats. Br J Med Med Res. 2013;3(4):2031-2041.
Ferreira C, Sousa M, Oliveira PF, Alves MG, Sa R. Impact of metformin on male reproduction. Curr Pharm Des. 2015;21(25):3621-3633. PMID: 26166607.
Franca L, Auharek S, Hess R, Dufour J, Hinton B. Blood tissue barriers: Morphofunctional and immunological aspects of the blood-testis and blood-epididymis barriers. Adv Exp Med Biol. 2012;763:237-259. PMID: 23397628.
Hakim P, Sani HA, Noor MM. Effects of Gynura procumbens and glibenclamide on sperm quality and specific activity of testicular lactate dehydrogenase in streptozocin-induced diabetic rats. Malay J Biochem Mol Biol. 2008;16(2):10-14.
Harrigan RA, Nathan MS, Beattie P. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity and treatment. Ann Emerg Med. 2001;38(1):68-78. doi: 10.1067/mem.2001.114314.
» https://doi.org/10.1067/mem.2001.114314
Hassan AA, Hassounna MM, Taketo T, Gagnob C, Elhilali MM. The effects of diabetes on sexual behaviour and reproductive tract function in male rats. J Urol. 1993;149(1):148-154.
ILAR (Institute for Laboratory Animal Research), Guide for the Care and Use of Laboratory Animals. National Research Council. (2006) No. 21 - 55. National Academic Press, Washington, D.C. doi: 10.17226/5140.
» https://doi.org/10.17226/5140
Kao SH, Chao HT, Chen HW, Hwang TS, Liao TL, Wei YH. Increase of oxidative stress in human sperm with lower motility. Fertil Steril. 2008;89(5):1183-1190. doi: 10.1016/j.fertnstert.2007.05.029.
» https://doi.org/10.1016/j.fertnstert.2007.05.029
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycaemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343. doi: 10.2337/dc099032.
» https://doi.org/10.2337/dc099032
Kumar P, Kumar N, Singh D, Patidar A. Male hypogonadism: symptoms and treatment. J Adv Pharm Technol Res. 2010;1(3):297-301. doi: 10.4103/0110-5558.72420.
» https://doi.org/10.4103/0110-5558.72420
Lan ZJ, Labus JC, Hinton BT. Regulation of gamma-glutamyl transpeptidase catalytic activity and protein. Level in the initial segment of the rat epididymis by testicular factors: role of basic fibroblast growth factor. Biol Reprod. 1998;58(1):197206. PMID: 9472941.
Luna B, Feingloss MN. Oral agents in the management of type 2 diabetes mellitus. Am Fam Physician. 2001;63(9):17471756. PMID: 11352285.
Mansfield R, Galea R, Brincat M, Hole D, Manso H. Metformin has direct effects on human ovarian steroidogenesis. Fertil Steril. 2003;79(4):956-962. PMID: 12749437.
Mathieu C, Degrande E. Vildagliptin: a new oral treatment for type 2 diabetes mellitus. Vasc Health Risk Manag. 2008;4(6):1349-1360. PMID: 19337548.
Moses RG, Colaguiri S, Pollock P. SGLT 2 inhibitors: new medicines for addressing unmet needs in type 2 diabetes. Australas Med J. 2014;7(10):405-415. doi: 10.4066/ AMJ.2014.2181.
» https://doi.org/10.4066/AMJ.2014.2181
Ozumba BC, Obi SN, Oli JM. Diabetes mellitus in pregnancy in an African population. Int J Gynaecol Obstet. 2004;84(2):114-119. doi: 10.1016/S0020-7292(03)00210-8.
» https://doi.org/10.1016/S0020-7292(03)00210-8
Prato SD. Dipeptidyl peptidase-4 Inhibition and Vildagliptin therapy for type 2 diabetes. Int J Clin Pract Suppl. 2007; 154: 38-48. doi: 10.1111/j.1742-1241.2007.01439.x
» https://doi.org/10.1111/j.1742-1241.2007.01439.x
Raji Y, Ifabunmi SO, Akinsomisoye OS, Morakinyo AO, Oloyo AK. Gonadal responses to antipsychotic drugs. Chlorpromazine and Thioridazine reversibly suppress testicular functions in albino rats. Intl J Pharmacol. 2005;1(3):287-292. doi: 10.3923/ijp.2005.287.292.
» https://doi.org/10.3923/ijp.2005.287.292
Setchell BP. Blood-testis barrier, junctional and transport proteins and spermatogenesis. Adv Exp Med Biol. 2008;636:212-223. doi: 10.1007/978-0-387-09597-4_12.
» https://doi.org/10.1007/978-0-387-09597-4_12
Snedecor GW, Cochran WG. Statistical methods. Ed. (1980) Pp. 215, 7 Ames, Iowa State University Press, Iowa.
W.H.O. 1987: World Health Organization, Laboratory manual for Examination of Human Semen and Semen-Cervical Mucus Interaction. 2nd ed. London. (1987) pp. 1-10. Cambridge University Press, USA.
WHO. Global Status Report on Non-communicable Diseases 2014. World Health Organization, Geneva, 2014.
Wilson M. Haematoxylin and Eosin 101: Part One- Method and Tips. Microscopy and Imaging, Bitesizebio. 2013; 1st edition: p46.
Wong CH, Cheng CY. The blood-testis barrier: its biology, regulation, and physiological role in spermatogenesis. Curr Top Dev Biol. 2005;71:263-296. doi: 10.1016/S00702153(05)71008-5.
» https://doi.org/10.1016/S00702153(05)71008-5
Zhao H, Piao C, Gong S. Diabetic damage to the male reproductive system and its mechanisms. Zhongua Nan Ke Xue. 2004;10(10):767-770. PMID: 15562793.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
